三星医疗(601567) - 2018 Q1 - 季度财报

Financial Performance - Operating revenue for the period reached CNY 1.15 billion, a 24.46% increase year-on-year[6] - Net profit attributable to shareholders was CNY 99.76 million, reflecting a 2.61% increase from the same period last year[6] - The company reported a basic earnings per share of CNY 0.07, unchanged from the previous year[6] - The company's operating revenue for Q1 2018 was CNY 357,326,045.85, an increase of 17.5% compared to CNY 304,184,119.45 in the same period last year[29] - The net profit for Q1 2018 was CNY 99,742,823.52, slightly up from CNY 98,990,883.91, reflecting a growth of 0.76% year-over-year[27] - The company reported a total profit of CNY 133,575,711.87 for Q1 2018, up from CNY 126,105,840.05 in the previous year, marking a growth of 5.8%[27] - The total comprehensive income for Q1 2018 was CNY 80,827,581.41, down from CNY 111,720,124.47 in Q1 2017, indicating a decline of 27.7%[28] Cash Flow and Liquidity - The net cash flow from operating activities was negative at CNY -136.58 million, worsening by 9.09% compared to the previous year[6] - Cash flow from operating activities was CNY 1,187,608,952.77 in Q1 2018, slightly down from CNY 1,220,264,304.54 in the previous year[31] - The net cash flow from operating activities was -136,580,517.06 RMB, compared to -125,199,072.06 RMB in the previous period, indicating a decline in operational cash flow[32] - Cash and cash equivalents at the end of the period totaled 1,051,179,426.31 RMB, down from 2,257,518,119.17 RMB in the previous period[33] - The cash flow from operating activities showed a net increase of 382,857,154.32 RMB, a turnaround from -357,639,361.49 RMB in the previous period, indicating improved operational efficiency[35] Assets and Liabilities - Total assets increased by 8.84% to CNY 13.83 billion compared to the end of the previous year[6] - The total current assets reached ¥6,080,940,627.40, up from ¥5,587,073,609.83[17] - Current liabilities rose to ¥4,458,294,005.22, an increase of 13.6% from ¥3,923,184,164.46 at the start of the year[19] - Non-current liabilities totaled ¥1,650,200,799.80, up 37.2% from ¥1,202,563,575.32 at the beginning of the year[19] - The company's equity attributable to shareholders reached ¥7,656,843,854.96, compared to ¥7,516,494,968.79 at the beginning of the year, reflecting a growth of 1.9%[19] Shareholder Information - The number of shareholders reached 27,572, with the top ten shareholders holding a significant portion of shares[9] - The largest shareholder, Aux Group Co., Ltd., holds 32.08% of the shares, totaling 457,719,653 shares[9] Investment and Expenses - Investment income rose by 32.93% to ¥15,038,716.28, mainly from cash dividends received[12] - Sales expenses increased by 36.62% to ¥104,331,026.83, reflecting the company's growth in scale[12] - The company experienced a financial expense of CNY 11,738,202.92 in Q1 2018, compared to a financial income of CNY 3,091,712.61 in the same period last year[27] Other Financial Metrics - The weighted average return on equity decreased by 0.11 percentage points to 1.30%[6] - The gross profit margin improved to 25.4% in Q1 2018, compared to 27.9% in Q1 2017, indicating a decrease in profitability despite higher revenues[29] - The company has not disclosed any new product developments or market expansion strategies in this report[6]